tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market
Advertisement

Immunovant (IMVT) Technical Analysis

Compare
898 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Immunovant is a Buy.
Immunovant’s (IMVT) 20-Day exponential moving average is 15.58, while Immunovant’s (IMVT) share price is $15.67, making it a Buy.
Immunovant’s (IMVT) 50-Day exponential moving average is 15.80, while Immunovant’s (IMVT) share price is $15.67, making it a Sell.

Immunovant (IMVT) Pivot Points

Sep 26, 2025, 09:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.04
14.52
14.99
15.47
15.94
16.42
16.89
Fibonacci
14.52
14.88
15.11
15.47
15.83
16.06
16.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Sep 26, 2025, 09:13 PM
Period
Simple
Exponential
MA5
15.28Buy
15.42Buy
MA10
15.39Buy
15.47Buy
MA20
15.71Sell
15.58Buy
MA50
15.95Sell
15.80Sell
MA100
15.79Sell
16.45Sell
MA200
18.17Sell
19.22Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 15.47, while Immunovant’s (IMVT) share price is $15.67, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 16.45, while Immunovant’s (IMVT) share price is $15.67, making it a Sell.
Immunovant’s (IMVT) stock price is $15.67 and Immunovant’s (IMVT) 50-day simple moving average is 15.95, creating a Sell signal.
Immunovant’s (IMVT) stock price is $15.67 and Immunovant’s (IMVT) 100-day simple moving average is 15.79, creating a Sell signal.
Immunovant’s (IMVT) stock price is $15.67 and Immunovant’s (IMVT) 200-day simple moving average is 18.17, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Sep 26, 2025, 09:13 PM
Name
Value
Implied Action
RSI (14)
50.30
Neutral
STOCH (9,6)
38.48
Neutral
STOCHRSI (14)
28.05
Neutral
MACD (12,26)
-0.12
Buy
ADX (14)
24.32
Neutral
Williams %R
-59.18
Buy
CCI (14)
-10.45
Neutral
ATR (14)
0.82
-
Ultimate Oscillator
38.58
Neutral
ROC
-8.58
Sell
Immunovant’s (IMVT) Relative Strength Index (RSI) is 50.30, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 24.32, creating a Neutral signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is -10.45, creating a Neutral signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is -8.58, creating a Sell signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Hold.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 50.30, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is -0.12, which suggests IMVT is a Buy.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 15.28, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 15.71, which suggests IMVT is a Sell.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 15.95, which suggests IMVT is a Sell.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 18.17, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -59.18, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is -10.45, which suggests IMVT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis